The researchers further proposed a new classification system for the disease that includes epithelial subtype, microsatellite status, and whether fibrosis is present.

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

The agency had originally planned to delete unspecified diagnosis codes for certain cancer tests covered under a national coverage decision.

The test detects variants in the POMC, PCSK1, and LEPR genes to identify individuals eligible for treatment with Rhythm Pharmaceuticals' recently approved Imcivree.

The company plans to launch a commercial product sometime after completing its currently ongoing Series A funding round. 

With electronic health record and tumor panel sequence data from tens of thousands of cancer cases, researchers tallied relationships between gene alterations and patient outcomes.

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

The companies will build a diverse research cohort with multiomics data and apply AI as they seek to improve diagnostics and advance drug discovery.

The firm also plans to submit the assay to the US Food and Drug Administration for Emergency Use Authorization in the coming weeks.

Analysis of 7,500 patients showed one-third had potentially actionable mutations and 10 percent were misdiagnosed, prompting calls for greater NGS use in this setting.

Scientists from the University of Florence in Italy applied nanopore sequencing to effectively detect known copy number variants in a small cohort of patients.

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

The PCR-based assay uses an extraction-free multiplex reagent to test orthopoxvirus and monkeypox gene targets in skin lesion samples. 

The San Jose, California-based infectious disease diagnostics company said it will use the funds to scale its production capacity and to add to its menu of tests.

The institute has awarded funding to a total of 12 sites to perform proteogenomic analyses on tumor samples and to study drug response and resistance.

China may soon have its own mRNA-based vaccine, according to Nature News.

The deal is the second of its kind for the two companies following a 2020 partnership to investigate metagenomic markers of different IBD patient phenotypes.

For PerkinElmer and SummerBio, the moves reflect weakening demand for COVID-19 testing, while the Siemens layoffs are linked to a manufacturing consolidation project.

The companies will codevelop, validate, and commercialize a companion diagnostic for Acrivon's targeted DNA damage response inhibitor therapy, ACR-368.

Under the agreement, Proteomics International has the right to use the markers to develop and commercialize a blood-based early detection test for esophageal cancer.

The researchers conducted a longitudinal household contacts-based study of genetic ancestry and tuberculosis disease progression.

The kit is provided in a 48-well microplate format and is compatible with automated reaction protocols.

The firm said it was laying off staff due to economic challenges and the US government's decision to reduce funding for COVID-19 testing.